MapLight Therapeutics, Inc. (MPLT)
29.28
+1.48
(+5.32%)
USD |
NASDAQ |
Jun 11, 11:08
MapLight Therapeutics Market Cap : 1.324B for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 1.257B |
| June 09, 2026 | 1.323B |
| June 08, 2026 | 1.332B |
| June 05, 2026 | 1.266B |
| June 04, 2026 | 1.361B |
| June 03, 2026 | 1.281B |
| June 02, 2026 | 1.236B |
| June 01, 2026 | 1.345B |
| May 29, 2026 | 1.325B |
| May 28, 2026 | 1.346B |
| May 27, 2026 | 1.340B |
| May 26, 2026 | 1.336B |
| May 22, 2026 | 1.304B |
| May 21, 2026 | 1.328B |
| May 20, 2026 | 1.261B |
| May 19, 2026 | 1.228B |
| May 18, 2026 | 1.202B |
| May 15, 2026 | 1.303B |
| May 14, 2026 | 1.328B |
| May 13, 2026 | 1.391B |
| May 12, 2026 | 1.374B |
| May 11, 2026 | 1.364B |
| May 08, 2026 | 1.163B |
| May 07, 2026 | 1.239B |
| May 06, 2026 | 1.232B |
| Date | Value |
|---|---|
| May 05, 2026 | 1.185B |
| May 04, 2026 | 1.214B |
| May 01, 2026 | 1.303B |
| April 30, 2026 | 1.352B |
| April 29, 2026 | 1.285B |
| April 28, 2026 | 1.286B |
| April 27, 2026 | 1.300B |
| April 24, 2026 | 1.263B |
| April 23, 2026 | 1.235B |
| April 22, 2026 | 1.363B |
| April 21, 2026 | 1.172B |
| April 20, 2026 | 1.203B |
| April 17, 2026 | 1.275B |
| April 16, 2026 | 1.210B |
| April 15, 2026 | 1.142B |
| April 14, 2026 | 1.147B |
| April 13, 2026 | 1.116B |
| April 10, 2026 | 1.134B |
| April 09, 2026 | 1.248B |
| April 08, 2026 | 1.029B |
| April 07, 2026 | 1.024B |
| April 06, 2026 | 959.48M |
| April 02, 2026 | 898.38M |
| April 01, 2026 | 883.95M |
| March 31, 2026 | 862.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Mineralys Therapeutics, Inc. | 1.951B |
| Evommune, Inc. | 744.14M |
| Arrowhead Pharmaceuticals, Inc. | 10.42B |
| Oncolytics Biotech, Inc. | 92.83M |
| Sangamo Therapeutics, Inc. | 61.73M |
Market Cap Related Metrics
| PEG Ratio | -0.0384 |
| Price to Book Value | 3.311 |
| Price | 29.28 |
| Earnings Yield | -15.43% |
| PEGY Ratio | -0.0384 |